Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anouck Kluytmans

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Frontiers in Psychology|February 1, 2012
Illustrating bayesian evaluation of informative hypotheses for regression modelsAnouck Kluytmans, Rens van de Schoot, Joris Mulder, et al.
Prostate Cancer and Prostatic Diseases|January 22, 2019
Exploring the risk-reward balance in focal therapy for prostate cancer-a contribution to the debateAnouck Kluytmans, Jurgen J Fütterer, Mark Emberton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2019
Early Assessment of Proof-of-Problem to Guide Health InnovationAnouck Kluytmans, Marcia Tummers, Gert Jan van der Wilt, et al.
Frontiers in Psychology|February 20, 2014
Analyzing indirect effects in cluster randomized trials. The effect of estimation method, number of groups and group sizes on accuracy and powerJoop J Hox, Mirjam Moerbeek, Anouck Kluytmans, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 16, 2022
Methods for Early Assessment of the Societal Value of Health Technologies: A Scoping Review and Proposal for ClassificationJanneke P C Grutters, Anouck Kluytmans, Gert Jan van der Wilt, et al.
Frontiers in Psychology|October 30, 2013
Facing off with Scylla and Charybdis: a comparison of scalar, partial, and the novel possibility of approximate measurement invarianceRens van de Schoot, Anouck Kluytmans, Lars Tummers, et al.
Cognitive, Affective & Behavioral Neuroscience|July 14, 2016
P300 amplitude variations, prior probabilities, and likelihoods: A Bayesian ERP studyBruno Kopp, Caroline Seer, Florian Lange, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative ProcessesRob Baltussen, Maarten Paul Maria Jansen, Leon Bijlmakers, et al.
Clinical Chemistry and Laboratory Medicine|July 10, 2019
Clinical biomarker innovation: when is it worthwhile?Anouck Kluytmans, Jaap Deinum, Kevin Jenniskens, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Psychology|February 1, 2012
Illustrating bayesian evaluation of informative hypotheses for regression modelsAnouck Kluytmans, Rens van de Schoot, Joris Mulder, et al.
Prostate Cancer and Prostatic Diseases|January 22, 2019
Exploring the risk-reward balance in focal therapy for prostate cancer-a contribution to the debateAnouck Kluytmans, Jurgen J Fütterer, Mark Emberton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2019
Early Assessment of Proof-of-Problem to Guide Health InnovationAnouck Kluytmans, Marcia Tummers, Gert Jan van der Wilt, et al.
Frontiers in Psychology|February 20, 2014
Analyzing indirect effects in cluster randomized trials. The effect of estimation method, number of groups and group sizes on accuracy and powerJoop J Hox, Mirjam Moerbeek, Anouck Kluytmans, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 16, 2022
Methods for Early Assessment of the Societal Value of Health Technologies: A Scoping Review and Proposal for ClassificationJanneke P C Grutters, Anouck Kluytmans, Gert Jan van der Wilt, et al.
Frontiers in Psychology|October 30, 2013
Facing off with Scylla and Charybdis: a comparison of scalar, partial, and the novel possibility of approximate measurement invarianceRens van de Schoot, Anouck Kluytmans, Lars Tummers, et al.
Cognitive, Affective & Behavioral Neuroscience|July 14, 2016
P300 amplitude variations, prior probabilities, and likelihoods: A Bayesian ERP studyBruno Kopp, Caroline Seer, Florian Lange, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative ProcessesRob Baltussen, Maarten Paul Maria Jansen, Leon Bijlmakers, et al.
Clinical Chemistry and Laboratory Medicine|July 10, 2019
Clinical biomarker innovation: when is it worthwhile?Anouck Kluytmans, Jaap Deinum, Kevin Jenniskens, et al.
Pageof 1